{"id":196517,"title":"Draft Guidance Document - Disclosure of Confidential Business Information under Paragraph 21.1(3)(c) of the Food and Drugs Act - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T06:00:25.061000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/draft-guidance-document-disclosure-confidential-business-information-under-paragraph-21-1-3-food-drugs-act.html?wbdisable=true","snippet":"Draft Guidance Document - Disclosure of Confidential Business Information under Paragraph 21.1(3)(c) of the Food and Drugs Act - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection Français fr / Gouvernement du Canada Search Search…","rawSnapshotUrl":"/api/snapshots/raw/196517","browseUrl":"https://replay.healtharchive.ca/job-1/20250419060025/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/draft-guidance-document-disclosure-confidential-business-information-under-paragraph-21-1-3-food-drugs-act.html?wbdisable=true#ha_snapshot=196517","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}